Literature DB >> 11121525

Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus.

V Mendoza-Fernández1, R D Andrew, C Barajas-López.   

Abstract

Interferons (IFN) appear to have various neuromodulatory actions. Here, we characterized the actions of IFN-alpha on the electrophysiological properties of CA1 hippocampal neurons using intracellular recordings. Superfusion of this cytokine did not alter the resting membrane potential, cell input resistance, action potentials, nor GABA-mediated fast synaptic potentials. IFN-alpha inhibited glutamate-mediated excitatory postsynaptic potentials (gEPSPs) and reversed or prevented long-term potentiation (LTP) induced by high-frequency tetanic stimulation. IFN-alpha reduced gEPSP amplitude far below its control value. Only a short-term potentiation (STP) was observed when either IFN-alpha or D-2-amino-5-phosphonovalerato (APV; NMDA receptor antagonist) were present during tetanic stimulation. After this STP in presence of APV, IFN-alpha had no effect on gEPSPs. APV had no effect on LTP when applied after tetanic stimulation and did also not prevent IFN-alpha effect on LTP. Genistein (a tyrosine kinase inhibitor) or heat inactivation prevented IFN-alpha effects. IFN-alpha also decreased the depolarization induced by local application of glutamate but did not modify those induced by NMDA. Similarly, IFN-alpha reversed the potentiation (induced by tetanic stimulation) of glutamate-induced depolarizations. IFN-alpha did not affect long-term depression (LTD) induced by low-frequency tetanic stimulation. In conclusion, IFN-alpha-induced inhibition of LTP is, at least in part, mediated by a postsynaptic effect, by tyrosine kinase activity, and by non-NMDA glutamate receptors. Inhibition of LTP by IFN-alpha unmasks LTD which is induced by the same high-frequency tetanic stimulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121525     DOI: 10.1016/s0006-8993(00)02877-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  Central and peripheral cytokines mediate immune-brain connectivity.

Authors:  Hugo O Besedovsky; Adriana del Rey
Journal:  Neurochem Res       Date:  2010-09-04       Impact factor: 3.996

2.  Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus.

Authors:  Stefan Kunz; Jillian M Rojek; Amanda J Roberts; Dorian B McGavern; Michael B A Oldstone; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain.

Authors:  Anthony N van den Pol; Michael D Robek; Prabhat K Ghosh; Koray Ozduman; Prasanthi Bandi; Matthew D Whim; Guido Wollmann
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

4.  Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.

Authors:  Elzbieta Jacek; Brian A Fallon; Abhishek Chandra; Mary K Crow; Gary P Wormser; Armin Alaedini
Journal:  J Neuroimmunol       Date:  2012-11-08       Impact factor: 3.478

5.  Environmental enrichment attenuates hippocampal neuroinflammation and improves cognitive function during influenza infection.

Authors:  Heidi A Jurgens; Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2012-06-09       Impact factor: 7.217

Review 6.  Astrocytes and synaptic plasticity in health and disease.

Authors:  A Singh; Wickliffe C Abraham
Journal:  Exp Brain Res       Date:  2017-03-15       Impact factor: 1.972

7.  Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells.

Authors:  Guido Wollmann; Michael D Robek; Anthony N van den Pol
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

8.  Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor.

Authors:  Cari F Kessing; William R Tyor
Journal:  J Interferon Cytokine Res       Date:  2014-12-17       Impact factor: 2.607

Review 9.  Neuropsychiatric adverse effects of interferon-alpha: recognition and management.

Authors:  Charles L Raison; Marina Demetrashvili; Lucile Capuron; Andrew H Miller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 10.  A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

Authors:  Rushaniya A Khairova; Rodrigo Machado-Vieira; Jing Du; Husseini K Manji
Journal:  Int J Neuropsychopharmacol       Date:  2009-02-19       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.